Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-17-005183
Filing Date
2017-05-15
Accepted
2017-05-15 13:59:22
Documents
57
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0317_actiniumpharma.htm 10-Q 616233
2 EMPLOYMENT AGREEMENT, DATED SEPTEMBER 17, 2015, BY AND BETWEEN ACTINIUM PHARMACE f10q0317ex10ii_actinium.htm EX-10.2 33430
3 EMPLOYMENT AGREEMENT, DATED SEPTEMBER 17, 2015, BY AND BETWEEN ACTINIUM PHARMACE f10q0317ex10iii_actinium.htm EX-10.3 84841
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER f10q0317ex31i_actiniumpharm.htm EX-31.1 11882
5 CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER f10q0317ex31ii_actiniumpharm.htm EX-31.2 13034
6 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER f10q0317ex32i_actiniumpharm.htm EX-32.1 4711
7 CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER f10q0317ex32ii_actiniumpharm.htm EX-32.2 5982
14 GRAPHIC ex10iii_001.jpg GRAPHIC 6412
  Complete submission text file 0001213900-17-005183.txt   3274626

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE atnm-20170331.xml EX-101.INS 489093
9 XBRL SCHEMA FILE atnm-20170331.xsd EX-101.SCH 39402
10 XBRL CALCULATION FILE atnm-20170331_cal.xml EX-101.CAL 22324
11 XBRL DEFINITION FILE atnm-20170331_def.xml EX-101.DEF 133485
12 XBRL LABEL FILE atnm-20170331_lab.xml EX-101.LAB 348986
13 XBRL PRESENTATION FILE atnm-20170331_pre.xml EX-101.PRE 226195
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36374 | Film No.: 17843135
SIC: 2834 Pharmaceutical Preparations